NUNNARI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 6.218
EU - Europa 4.712
AS - Asia 2.090
AF - Africa 9
SA - Sud America 9
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.045
Nazione #
US - Stati Uniti d'America 6.116
IE - Irlanda 1.841
SE - Svezia 1.064
CN - Cina 981
SG - Singapore 899
IT - Italia 827
PL - Polonia 465
FR - Francia 126
FI - Finlandia 104
CA - Canada 100
DE - Germania 97
VN - Vietnam 76
IN - India 68
GB - Regno Unito 46
UA - Ucraina 31
BE - Belgio 27
ID - Indonesia 22
NL - Olanda 19
RU - Federazione Russa 16
AT - Austria 14
KR - Corea 13
CZ - Repubblica Ceca 12
LT - Lituania 8
TH - Thailandia 8
CH - Svizzera 6
HK - Hong Kong 5
AU - Australia 4
BG - Bulgaria 3
BR - Brasile 3
CL - Cile 3
JP - Giappone 3
NP - Nepal 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
EU - Europa 2
IQ - Iraq 2
IR - Iran 2
JO - Giordania 2
UG - Uganda 2
AL - Albania 1
AZ - Azerbaigian 1
CO - Colombia 1
ES - Italia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TR - Turchia 1
VE - Venezuela 1
Totale 13.045
Città #
Dublin 1.841
Chandler 1.385
Singapore 752
Nyköping 746
Warsaw 464
Princeton 437
Beijing 421
Dearborn 384
Jacksonville 317
Medford 304
Des Moines 249
Messina 187
Ann Arbor 174
Boardman 166
Ashburn 159
Wilmington 129
Ottawa 89
Houston 86
New York 84
Jinan 75
Dong Ket 74
Rome 69
Cambridge 68
Shenyang 67
Nanjing 56
Helsinki 54
San Mateo 53
Seattle 50
Pune 48
Falls Church 47
Woodbridge 32
Los Angeles 31
Bremen 30
Zhengzhou 30
Norwalk 28
Brussels 27
Milan 27
Tianjin 27
Guangzhou 26
Redwood City 26
Haikou 25
Caltagirone 24
Hangzhou 24
Hebei 23
Catania 21
Jakarta 19
Taizhou 19
Nanchang 17
Philadelphia 17
Fairfield 16
Ningbo 15
Changsha 13
Lanzhou 13
Vienna 13
Brno 12
Munich 12
Naples 12
Fuzhou 10
Jiaxing 10
Mountain View 10
Palermo 10
Bologna 9
Kunming 9
Milazzo 9
Misterbianco 9
Portici 9
West Lafayette 9
Bari 8
Belpasso 8
Richmond 8
Sassari 8
Tappahannock 8
Yangcheon-gu 8
Amsterdam 7
Borghetto Santo Spirito 7
Lancaster 7
Reggio Calabria 7
Cagliari 6
Nuremberg 6
Taiyuan 6
The Dalles 6
Toronto 6
Clearwater 5
Florence 5
Hyderabad 5
St Louis 5
Castelbuono 4
Chiavari 4
Hefei 4
Imola 4
Paris 4
Santa Clara 4
Seodaemun-gu 4
Shanghai 4
Sydney 4
Washington 4
Yantai 4
Zurich 4
Aci Bonaccorsi 3
Aci Catena 3
Totale 9.888
Nome #
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 399
MALATTIE INFETTIVE E TROPICALI PER STUDENTI E MEDICI DI MEDICINA GENERALE 143
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 133
Breast cancer in women living with HIV 116
Anal cancer in people living with HIV: the importance of the screening and of early diagnosis 105
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. 102
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals 98
Epidemiologia delle farmacoresistenze di HIV nella regione Sicilia 92
Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy 91
Sindrome di Castelman in paziente affetto da HIV e con sospetto Sarcoma di Kaposi. 89
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudina/Dolutegravir Therapy in Human Immunodeficiency Virus Treatment-Experienced Patients. 86
Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily. 83
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate 82
Contribution of naive CD4+T cells to the intact HIV reservoir 81
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 79
Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review 78
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 78
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 77
null 76
Prostate cancer in HIV-positive patients: a review of the literature 75
Circulating angiopoietin‑like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 75
Health status and Quality of life in people living with HIV (PLWH): results from the ICONA cohort 74
Comparative neuropsychiatric toxicity profile of dolutegravir versus efavirenz versus other antiretroviral third drugs used either in first-line or switching antiretroviral therapies (ART): data from ICONA Foundation Study Cohort 74
Anxiety disorders and adherence to HAART 72
null 71
Tache Noire in a Patient with Acute Q Fever 71
Ocular surface manifestation of COVID-19 and tear film analysis 70
Comparative neuropsychiatric toxicity profile of dolutegravir (DGT)-based versus efavirenz (EFV)-based versus other recommend first-line antiretroviral therapies (ART): data from ICONA Foundation Study Cohort. 69
Awareness and perception of accurancy of the Undetectable=Untransmittable (U=U) message in people living with HIV/AIDS (PLWHA), in Italy and correlation with the level of confidence in reference physicians. 69
Nail pigmentation and fatigue. 67
HIV associated psoriasis: epidemiology, pathogenesis and management 67
Epidemiologia delle farmacoresistenza di HIV nella Regione Sicilia. 67
HIV and Colorectal Cancer. New Insights and Review of the Literature 66
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 65
Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis 64
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project 62
Transmission mode associated with coronavirus disease 2019: a review 62
Pityriasis rosea during etanercept therapy. 61
Effect of simplification to INSTI-based dual therapy on residual inflammation and viral reservoir 60
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? 60
Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection 59
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). 59
The new era of vaccines: the “nanovaccinology” 59
Durability of F/TAF-based regimens in a large cohort of PLWH seen of care in Italy 57
Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience 57
HPV AND URINARY BLADDER CARCINOMA: A REVIEW OF THE LITERATURE 56
Malignant melanoma in HIV: epidemiology, pathogenesis and management 56
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: Review of the literature and suggestions for a friendly use 56
Bone safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-Word Cohort. 56
New and old assumptions of lung cancer in people living with HIV 56
Cervical and lumbar diffuse Brucella spondylodiscitis: an uncommon case report 55
Impact of multi-drug resistance on mortality: a multi-cohort Italian study. 54
null 53
HIV-RNA CD4/CD8 ratio and HDL concentration in a cohort of HIV + ART-naïve patients. 53
Incidence and risk factors for liver enzyme elevation among naïve HIV-1 infected patients receiving ART in the ICONA cohort 53
Epatite A: immunità e accettazione della profilassi vaccinale in una coorte siciliana di pazienti con infezione da HIV. Dati preliminari. 53
ANAL CANCER IN HIV-POSITIVE PATIENTS 53
Factors Associated With Weight Gain in People Treated With Dolutegravir 53
Achromobacter xylosoxidans meningitis in an immunosuppressed patient 52
Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients 52
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 52
Epstein Barr Virus related cancer in people living with HIV: a review of the literature 52
The role of the hospital environment in the healthcare-associated infections: a general review of the literature 51
Cervical and lumbar diffuse Brucella spondylodiscitis: an uncommon case report 51
Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient 51
THE UNDESIRED FELLOW TRAVELLER 50
Are HIV/HCV co.infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the ICONA Foundation Study. 50
Epidemiology of the new HIV infections in a large university hospital of Southern Italy: the importance of increasing the culture of the HIV screening test in the prevention of late diagnosis 50
Definition of a novel vaccination pathway in PLWHA: experience of a Southern University Hospital 50
Acetyl-L-carnitine supplementation during HCV therapy with pegylated interferon-α 2b plus ribavirin: Effect on work performance; a randomized clinical trial 49
Genetic evidence that Naïve T cells can contribute significantly to the HIV intact reservoir: time to re-evaluate their role 49
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 49
Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial 48
Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. 48
Pre-ART HIV-1 DNA in CD4! T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 48
Is the rate of virological failure to cART continuing to decline in recent calendar years? 48
The Hepatitis C continuum of care among HIV infected individuals in the ICONA study network. 48
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 48
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for HIV-infected people. 47
The treatment of Kaposi’s sarcoma: present and future options, a review of the literature 47
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 47
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives 46
Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: An update of new immune-modulating approaches 46
Effectiveness of dolutegravir-based regimens as either first-line orswitch antiretroviral therapy: data from the Icona cohort 46
Incidence of dyslipidemia and modification of atherosclerotic cardiovascular disease (ASCVD) risk in HIV-infected patients who switch away from tenofovir disoproxil fumarato (TDF)-based to TDF-sparing regimens in the ICONA Foundation Cohort 46
Persistence of an intact HIV reservoir in phenotypically naive T cells 46
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 46
Tetanus immunity in construction workers in Italy 45
Acute non A-E hepatitis in eastern Sicily: the natural history and the role of hepatitis G virus. 45
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience 45
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study. 45
CD4/CD8 ratio in patients who switch cART therapy: triple drug regimen could be better than mono/dual? 44
Trends and determinants of viral suppression among persons on HIV care in Italy. 44
Predictors of access and response to DAA in a cohort of human immunodeficincy virus/hepatitis C virus co-infected patients in Italy. 44
Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies 44
Ampicillin plus ceftriaxone regimen against enterococcus faecalis endocarditis: A literature review 44
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 44
Un’epidemia di morbillo a catania, sicilia: l’importanza di un’elevata copertura vaccinale e della notifica precoce dei casi per ragioni sanitarie ed economiche 43
Changes of lipid profile after switching to E/C/F/TAF: data from the Italian Compassionate Use Program 43
Association between raised IL-8 serum levels and resistance to combined peg-interferon plus ribavirin therapy in HCV+ active chronic hepatitis. 43
Totale 6.493
Categoria #
all - tutte 72.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020931 0 0 0 0 0 0 120 114 114 331 169 83
2020/20211.838 62 77 380 147 398 117 136 112 104 126 71 108
2021/20222.113 36 147 28 88 129 45 163 110 64 105 273 925
2022/20235.596 714 348 190 476 400 514 99 328 2.268 29 164 66
2023/20241.215 152 205 111 101 80 212 33 53 9 35 18 206
2024/20251.288 110 79 118 448 422 105 6 0 0 0 0 0
Totale 14.574